Exploring the mechanism of kaji-ichigoside F1 on bacterial pneumonia based on the network pharmacology and transcriptome
Junlin Yang, Xi Yang, Liping Wu, Cheng Min
This study investigates how kaji-ichigoside F1 reduces bacterial pneumonia inflammation by targeting TLR and NFKB pathways, as shown through network pharmacology, molecular docking, and transcriptomic analysis.
bioRxiv · Apr 17, 2025 · PreprintPharmacology & Toxicology